Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study.
about
Angioplasty versus bare metal stenting for superficial femoral artery lesionsDrug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to dateFeasibility and Clinical Outcomes of Peripheral Drug-Coated Balloon in High-Risk Patients with Femoropopliteal DiseaseCritical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stent12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.Standards of practice for superficial femoral and popliteal artery angioplasty and stenting.Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.Short-term Results of the RAPID Randomized Trial of the Legflow Paclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of Intermediate and Long Superficial Femoral Artery Lesions.The endovascular approach for in-stent restenosis in femoropopliteal disease.Comparative Assessment of Guidewire and Microcatheter vs a Crossing Device-Based Strategy to Traverse Infrainguinal Peripheral Artery Chronic Total Occlusions.Drug-coated balloon and stent therapies for endovascular treatment of atherosclerotic superficial femoral artery disease.Effectiveness of Viabahn in the Treatment of Superficial Femoral Artery Occlusive Disease: A Systematic Review and Meta-analysis.JETSTREAM Atherectomy: A Review of Technique, Tips, and Tricks in Treating the Femoropopliteal Lesions.Evolution of patency rates of self-expandable bare metal stents for endovascular treatment of femoro-popliteal arterial occlusive disease: Does stent design matter?Early Post-Registry Experience With Drug-Eluting Stents in the Superficial Femoral Artery.[Stent-assisted recanalization of femoropopliteal arterial occlusive disease. Influence of stent design on patency rates].Current Status of Drug-Eluting Stents and Drug-Eluting Balloons for the Superficial Femoral Artery.Short vs prolonged dual antiplatelet treatment upon endovascular stenting of peripheral arteries.Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.Long-term outcomes of SMART stent implantation in patients with femoro-popliteal disease.Emerging stent and balloon technologies in the femoropopliteal arteries.Chronic vascular response after self-expanding nitinol stent implantation in superficial femoral arteries: a serial intravascular ultrasound analysis.Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial.Efficacy of treatment of edge stenosis of endografts inserted for superficial femoral artery stenotic disease.Swirling Flow and Wall Shear: Evaluating the BioMimics 3D Helical Centerline Stent for the Femoropopliteal Segment.
P2860
Q24193807-87EBEBED-26CD-43D2-B5BB-E2714BB83DBFQ26747772-C1DE4792-7012-4C9A-B54C-C1B2A9FADBD2Q28551128-EC1BB028-8B90-4E9E-B11E-0B15664D05BDQ33710114-757FD7E9-B0DC-42FD-9A3F-F2703EC4323DQ35150908-4705355B-3DE1-4B3C-8BBF-28B41145F899Q36920052-9A6EAF21-95AF-44D8-B0D5-B732E58C930FQ38203809-523C19F0-B957-4096-B6FA-3C54581FF05AQ38211926-1266E47A-330D-4B46-B3CE-CC7BA8F5CF77Q38372419-2259C669-AA30-4E8C-B50B-23393BAF4063Q38374297-0F5A0B0B-6CAE-4F09-99E4-79D265D646BBQ38411446-095E09EA-856E-445C-B35D-8CAEE50A83C2Q38430774-6345B9CA-0758-4ED2-A646-CA1D0E63DE7EQ38505073-8D554F6B-E5FD-44AC-950C-CF5148E7DACCQ38523273-00331177-BF57-4F75-B5FB-5C25423671BCQ38975005-5F26BE1B-02D9-4E01-9B6C-15F9CF93CB70Q40778613-47168853-2356-46FF-B676-447877FE2CEAQ40932289-888896F5-DF10-4C08-B7FA-4B0896EC74F0Q41965693-0E732585-AB93-4E76-A711-5C28CFB441BDQ44281721-9FA87DC4-BC98-439D-B9C9-1C83EAA934BDQ48103282-C37A7376-2560-4A95-9304-223835CF2E75Q48247913-53B8C46C-6DD7-454E-98B3-3F70D405285AQ51195575-7B3DFF72-CE7F-4FF0-B50E-BF4DFC358561Q51287405-1A011D3E-3D98-4E75-B099-34467FB701DAQ51614926-529260F3-575C-4E0B-B6E0-F99511947FDCQ53036848-B7A9D404-DCCE-42A9-B08C-A9F4901A4B80Q53200219-40C89503-D3DF-4197-B21F-1D2D99F148A5Q55071098-62AFA4B8-2706-4866-A336-10AF83110452
P2860
Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Randomized trial of the SMART ...... tery lesions: the SUPER study.
@en
Randomized trial of the SMART ...... tery lesions: the SUPER study.
@nl
type
label
Randomized trial of the SMART ...... tery lesions: the SUPER study.
@en
Randomized trial of the SMART ...... tery lesions: the SUPER study.
@nl
prefLabel
Randomized trial of the SMART ...... tery lesions: the SUPER study.
@en
Randomized trial of the SMART ...... tery lesions: the SUPER study.
@nl
P2093
P2860
P1476
Randomized trial of the SMART ...... tery lesions: the SUPER study.
@en
P2093
Anna-Maria Belli
Anthony P Thorpe
Graham Robinson
Mariella van Ransbeeck
Nicholas Chalmers
Paul T Walker
Steven A Fearn
P2860
P2888
P304
P356
10.1007/S00270-012-0492-Z
P577
2012-10-16T00:00:00Z